HHV-6 infection in HIV-infected asymptomatic and AIDS patients

被引:18
作者
Ablashi, DV
Marsh, S
Kaplan, M
Whitman, JE
Pearson, GR
机构
[1] Adv Biotechnol Inc, Columbia, MD 21046 USA
[2] Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC USA
[3] N Shore Univ Hosp, Ctr AIDS Res & Treatment, Manhasset, NY USA
关键词
HHV-6; infection; HIV; AIDS;
D O I
10.1159/000024909
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In order to investigate the levels of HHV-6 infection and elevated antibodies to HHV-6 in HIV-l-infected asymptomatic and symptomatic patients, peripheral blood mononuclear cells were (PBMC) cultured. As patients progressed from asymptomatic HIV infection to AIDS, there was a concurrent increase in replicating HHV-6. Plasma obtained from several of these patients showed the presence of IgM antibody and a significantly elevated level of HHV-6 IgG antibody. Serial samples of plasma from 10 AIDS patients collected over a period of 4 years were assayed for the detection of HHV-6 core protein (gp116/64/54) by antigen capture ELISA, The results demonstrated that either a persistent infection or reactivation can occur based on the degree of fluctuation in HHV-6 antigen detected. ELISA to HHV-6 purified viral proteins, i.e., early (p41/38) and late (gp 110), demonstrated that Ige antibody to gp110 did not differentiate between HIV-l-infected and healthy donors. IgG and IgM antibody to p41/38, however, showed a significantly higher prevalence in HIV-l-infected individuals (56.7-85.3%) than in normal healthy donors (19.0%), suggesting virus activation. PBMC culture from the AIDS patients expressing significant peaks of HHV-6 core antigen (gp116/64/54) in their plasma showed that in most cases, HHV-6 early and late antigens were detectable; however, those patients with consistently low antigen peaks had no detectable antigens in their PBMC, Only 55% of PBMC cultures established from IgM antibody-positive HIV-l-infected asymptomatic and AIDS patients expressed HHV-6 antigens in the short-term cultures, but HHV-6 antigens could not be demonstrated in PB MC culture from 4 IgM-antibody-positive healthy donors, HHV-6 isolates obtained from the HIV-l-positive patients were predominantly HHV-6 variant A, compared to healthy donors, Based on the data presented here, it is evident that the levels of HHV-6 infection increased in HIV-l-infected asymptomatic individuals as they progressed to AIDS, Our immunovirological data on HHV-6-infected individuals with HIV infection support a role for HHV-6 in the pathogenesis of AIDS. We believe that simultaneous active infection with HIV-1 and HHV-6 may contribute to enhanced immune suppression perhaps leading to disease manifestations.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 48 条
  • [1] HUMAN HERPESVIRUS-6 STRAIN GROUPS - A NOMENCLATURE
    ABLASHI, D
    AGUT, H
    BERNEMAN, Z
    CAMPADELLIFIUME, G
    CARRIGAN, D
    CECCERININELLI, L
    CHANDRAN, B
    CHOU, S
    COLLANDRE, H
    CONE, R
    DAMBAUGH, T
    DEWHURST, S
    DILUCA, D
    FOATOMASI, L
    FLECKENSTEIN, B
    FRENKEL, N
    GALLO, R
    GOMPELS, U
    HALL, C
    JONES, M
    LAWRENCE, G
    MARTIN, M
    MONTAGNIER, L
    NEIPEL, F
    NICHOLAS, J
    PELLETT, P
    RAZZAQUE, A
    TORRELLI, G
    THOMSON, B
    SALAHUDDIN, S
    WYATT, L
    YAMANISHI, K
    [J]. ARCHIVES OF VIROLOGY, 1993, 129 (1-4) : 363 - 366
  • [2] UTILIZATION OF HUMAN HEMATOPOIETIC-CELL LINES FOR THE PROPAGATION AND CHARACTERIZATION OF HBLV (HUMAN HERPESVIRUS-6)
    ABLASHI, DV
    LUSSO, P
    HUNG, CL
    SALAHUDDIN, SZ
    JOSEPHS, SF
    LLANA, T
    KRAMARSKY, B
    BIBERFELD, P
    MARKHAM, PD
    GALLO, RC
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (05) : 787 - 791
  • [3] Ablashi DV, 1997, IN VIVO, V11, P383
  • [4] HUMAN HERPESVIRUS-6 AS A POTENTIAL COPATHOGEN
    ABLASHI, DV
    BERNBAUM, J
    DIPAOLO, JA
    [J]. TRENDS IN MICROBIOLOGY, 1995, 3 (08) : 324 - 327
  • [5] GENOMIC POLYMORPHISM, GROWTH-PROPERTIES, AND IMMUNOLOGICAL VARIATIONS IN HUMAN HERPESVIRUS-6 ISOLATES
    ABLASHI, DV
    BALACHANDRAN, N
    JOSEPHS, SF
    HUNG, CL
    KRUEGER, GRF
    KRAMARSKY, B
    SALAHUDDIN, SZ
    GALLO, RC
    [J]. VIROLOGY, 1991, 184 (02) : 545 - 552
  • [6] IDENTIFICATION OF PROTEINS SPECIFIC FOR HUMAN HERPESVIRUS-6-INFECTED HUMAN T-CELLS
    BALACHANDRAN, N
    AMELSE, RE
    ZHOU, WW
    CHANG, CK
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (06) : 2835 - 2840
  • [7] HUMAN HERPESVIRUS-7 IS A T-LYMPHOTROPIC VIRUS AND IS RELATED TO, BUT SIGNIFICANTLY DIFFERENT FROM, HUMAN HERPESVIRUS-6 AND HUMAN CYTOMEGALOVIRUS
    BERNEMAN, ZN
    ABLASHI, DV
    LI, G
    EGERFLETCHER, M
    REITZ, MS
    HUNG, CL
    BRUS, I
    KOMAROFF, AL
    GALLO, RC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) : 10552 - 10556
  • [8] BLAZQUEZ MV, 1995, J ACQ IMMUN DEF SYND, V9, P389
  • [9] HUMAN HERPESVIRUS-6 (VARIANT-A) IN KAPOSIS-SARCOMA
    BOVENZI, P
    MIRANDOLA, P
    SECCHIERO, P
    STRUMIA, R
    CASSAI, E
    DILUCA, D
    [J]. LANCET, 1993, 341 (8855) : 1288 - 1289
  • [10] Human herpesvirus 6
    Braun, DK
    Dominguez, G
    Pellett, PE
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (03) : 521 - +